Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma
- PMID: 24737504
- DOI: 10.3892/mmr.2014.2151
Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma
Abstract
Autophagy is a cytoprotective process, which occurs following temozolomide (TMZ) treatment, and contributes to glioma chemoresistance and TMZ treatment failure. However, the molecular mechanisms by which TMZ induces autophagy are largely unknown. In the current study, the ataxia‑telangiectasia mutated (ATM) inhibitor KU‑55933, adenosine monophosphate‑activated protein kinase (AMPK) inhibitor compound C, and U87MG and U251 cell lines were employed to investigate the molecular mechanisms of TMZ‑induced autophagy in glioma, and to evaluate the effects of autophagy inhibition on TMZ cytotoxicity. KU‑55933 and compound C were observed to inhibit the activation of autophagy‑initiating kinase ULK1 and result in a significant decrease of autophagy as indicated by depressed LC3B cleavage and acidic vesicular organelle formation. The activation of AMPK‑ULK1 was ATM dependent. Autophagy inhibition via the AMPK inhibitor compound C augmented TMZ cytotoxicity as observed by depressed cell viability, increased γH2AX‑marked double‑strand breaks (DSBs) and elevated numbers of apoptotic glioma cells. In conclusion, TMZ induced autophagy via ATM‑AMPK‑ULK1 pathways. TMZ chemoresistance may therefore be overwhelmed by targeting AMPK, particularly for the treatment of O6‑methylguanine DNA methyltransferase‑negative gliomas.
Similar articles
-
MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangiectasia mutated in glioma.Mol Med Rep. 2015 Jun;11(6):4591-6. doi: 10.3892/mmr.2015.3293. Epub 2015 Feb 3. Mol Med Rep. 2015. PMID: 25646660
-
ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.J Neurooncol. 2012 Dec;110(3):349-57. doi: 10.1007/s11060-012-0979-0. Epub 2012 Oct 3. J Neurooncol. 2012. PMID: 23054561 Free PMC article.
-
The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.Neuropharmacology. 2017 Apr;116:300-314. doi: 10.1016/j.neuropharm.2016.12.011. Epub 2016 Dec 13. Neuropharmacology. 2017. PMID: 27986595
-
Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage.PLoS One. 2013;8(1):e55665. doi: 10.1371/journal.pone.0055665. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383259 Free PMC article.
-
Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.Biomed Pharmacother. 2018 Jan;97:844-850. doi: 10.1016/j.biopha.2017.10.146. Epub 2017 Nov 7. Biomed Pharmacother. 2018. PMID: 29136760
Cited by
-
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.Oxid Med Cell Longev. 2019 Oct 31;2019:8730816. doi: 10.1155/2019/8730816. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31781355 Free PMC article. Review.
-
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.Neurol Med Chir (Tokyo). 2018 Oct 15;58(10):405-421. doi: 10.2176/nmc.ra.2018-0141. Epub 2018 Sep 21. Neurol Med Chir (Tokyo). 2018. PMID: 30249919 Free PMC article. Review.
-
KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation.EMBO J. 2015 Oct 1;34(19):2441-64. doi: 10.15252/embj.201489838. Epub 2015 Aug 17. EMBO J. 2015. PMID: 26282792 Free PMC article.
-
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.Oncotarget. 2017 Dec 6;8(68):113090-113104. doi: 10.18632/oncotarget.23028. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348889 Free PMC article.
-
MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.Nat Commun. 2016 Dec 6;7:13701. doi: 10.1038/ncomms13701. Nat Commun. 2016. PMID: 27922010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous